14 April 2021
Hogan Lovells advises Spark Therapeutics on collaboration with Senti Biosciences
Advising firms
Deal team
2 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Adam Golden Lead | Hogan Lovells Cadwalader | Partner | Not stated | New York |
| Jeff Jay Lead | Hogan Lovells Cadwalader | Senior associate | Not stated | New York |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 645m (US$645 million)
- What the figure measures
- Not stated
- Client
- Spark TherapeuticsJoint venture party
- Counterparties
- Senti Biosciences (Joint venture party)